Litigation
Louisiana Health Service & Indemnity Company v. Celgene Corporation
motion to dismiss granted1:23-cv-07871
- Court
- S.D.N.Y.
- Filed
- 2023-09-05
Patents at issue (1)
Plaintiffs (1)
Defendants (1)
Summary
Antitrust action in S.D.N.Y. naming the '939 formulation patent as part of an alleged monopolization scheme. Motion to dismiss granted Mar. 2025; plaintiffs sought leave to amend.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
In the news
What the press has reported about this case, summarized with links to the source articles.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).